MUCOSAL IMMUNITY TO INFECTION WITH IMPLICATIONS FOR VACCINE DEVELOPMENT

被引：171
|
作者：
STAATS, HF
JACKSON, RJ
MARINARO, M
TAKAHASHI, I
KIYONO, H
MCGHEE, JR
机构：
[1] OSAKA UNIV,SUITA,OSAKA 565,JAPAN
[2] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
来源：
CURRENT OPINION IN IMMUNOLOGY | 1994年 / 6卷 / 04期
关键词：
D O I：
10.1016/0952-7915(94)90144-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The induction of effective mucosal immunity that also provides systemic immunity is a considerable challenge. Over the past two years, efforts to develop novel mucosal vaccine delivery systems to induce mucosal immunity against bacterial and viral diseases, including HIV, have dramatically increased. Here we cite novel vaccines and delivery systems being used to establish effective mucosal immunity.
引用
收藏
页码：572 / 583
页数：12
相关论文
共 50 条
  • [41] Indirect effects of cytomegalovirus infection: Implications for vaccine development
    Moseley, Philip
    Klenerman, Paul
    Kadambari, Seilesh
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [42] Mucosal Immunity and Candida albicans Infection
    Moyes, David L.
    Naglik, Julian R.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011, : 1 - 9
  • [43] Mucosal Immunity in Cervicovaginal Infection.
    Nold, Christopher J.
    Maubert, Monique
    Anton, Lauren
    Elovitz, Michal
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 297A - 298A
  • [44] Mucosal immunity in Toxoplasma gondii infection
    Schulthess, J.
    Fourreau, D.
    Darche, S.
    Meresse, B.
    Kasper, L.
    Cerf-Bensussan, N.
    Buzoni-Gatel, D.
    PARASITE, 2008, 15 (03) : 389 - 395
  • [45] A Bovine Enteric Mycobacterium Infection Model to Analyze Parenteral Vaccine-Induced Mucosal Immunity and Accelerate Vaccine Discovery
    Facciuolo, Antonio
    Lee, Amy H.
    Trimble, Michael J.
    Rawlyk, Neil
    Townsend, Hugh G. G.
    Bains, Manjeet
    Arsic, Natasa
    Mutharia, Lucy M.
    Potter, Andrew
    Gerdts, Volker
    Napper, Scott
    Hancock, Robert E. W.
    Griebel, Philip J.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
    Moradi-kalbolandi, Shima
    Majidzadeh-A, Keyvan
    Abdolvahab, Mohadeseh Haji
    Jalili, Neda
    Farahmand, Leila
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2021, 13 (05) : 1239 - 1253
  • [47] Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development
    Sui, Yongjun
    Berzofsky, Jay A.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [48] The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
    Shima Moradi-kalbolandi
    Keyvan Majidzadeh-A
    Mohadeseh Haji Abdolvahab
    Neda Jalili
    Leila Farahmand
    Probiotics and Antimicrobial Proteins, 2021, 13 : 1239 - 1253
  • [49] INDUCTION AND ASSESSMENT OF IMMUNITY AT ENTEROMUCOSAL SURFACES IN HUMANS - IMPLICATIONS FOR VACCINE DEVELOPMENT
    CZERKINSKY, C
    SVENNERHOLM, AM
    HOLMGREN, J
    CLINICAL INFECTIOUS DISEASES, 1993, 16 : S106 - S116
  • [50] Hepatitis C cross-genotype immunity and implications for vaccine development
    Nazrul Islam
    Mel Krajden
    Jean Shoveller
    Paul Gustafson
    Mark Gilbert
    Jason Wong
    Mark W. Tyndall
    Naveed Zafar Janjua
    Scientific Reports, 7
12345